Results 231 to 240 of about 83,344 (312)

Dissociation kinetics of G proteins from G protein-coupled receptors and effects of allosteric modulation. [PDF]

Proc Natl Acad Sci U S A
Wang J, Nguyen ATN, Adediwura VA, Lu CS, McNeill SM, Jörg M, Scammells PJ, Christopoulos A, May LT, Miao Y.   +9 more
europepmc   +1 more source

The purinergic signaling interfaces in breast cancer angiogenesis. [PDF]

Purinergic Signal
da Silva FC, Stabile J, Fürstenau CR, Araújo TG.   +3 more
europepmc   +1 more source

Therapeutic potential of adenosine receptor modulators in cancer treatment. [PDF]

RSC Adv
Maity P, Ganguly S, Deb PK.
europepmc   +1 more source

RETRACTED: Zuccarini et al. Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A₁ Receptor Ligands. <i>Cells</i> 2021, <i>10</i>, 3560. [PDF]

Cells
Zuccarini M, Lambertucci C, Carluccio M, Giuliani P, Ronci M, Spinaci A, Volpini R, Ciccarelli R, Di Iorio P.   +8 more
europepmc   +1 more source

The interaction of AB-680, a CD73 inhibitor, with NBTI, a nucleoside transporter inhibitor, on the adenosinergic control of atrial contractility. [PDF]

Front Pharmacol
Ovari I, Brezniczky AB, Laczovics A, Berényi E, Erdei T, Ojo O, Hornok B, Juhasz B, Szilvassy Z, Zsuga J, Viczjan G, Gesztelyi R.   +11 more
europepmc   +1 more source

Caffeine-associated reduction in patent ductus arteriosus is mediated in part by adenosine receptor antagonism. [PDF]

Am J Physiol Heart Circ Physiol
Crockett SL, Su RL, Sekulich DC, Goins KA, Montero A, Boatwright N, Berger CD, Yarboro MT, Paria BC, Herington JL, Siricilla S, Mettler BA, Bichell DP, Allison BJ, Reese J, Shelton EL.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Adenosine A1 receptors and erythropoietin production

American Journal of Physiology-Cell Physiology, 1993
N6-cyclopentyladenosine (CPA), a selective adenosine A1 receptor agonist, in a concentration range of 10(-9) to 10(-7) M, produced a significant decrease in erythropoietin (EPO) levels in a human hepatocellular carcinoma (Hep G2) cell culture (medium levels of EPO, 91.81 +/- 1.61 and 94.36 +/- 0.97% of control, respectively) after 24 h incubation in a
T, Ohigashi, J, Brookins, J W, Fisher
openaire   +2 more sources